Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00975 |
| Species: | Homo sapiens |
| Position : | chr5:122453050-122453374 |
| Year: | 2023 |
| Title: | Prdm6 drives ductus arteriosus closure by promoting ductus arteriosus smooth muscle cell identity and contractility |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 36749647 |
| MONDO: | MONDO:0011998 |
| Tissue: | Bone Marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR |
| Target gene : | PRDM6 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|